- As part of their broader strategic partnership,
EQT Private Equity and Mubadala Investment Company to make a majority investment in Envirotainer, a global provider of mission-critical cold chain transportation solutions for pharmaceuticals
- Envirotainer enables access to life-saving pharmaceuticals and vaccines via reliable and efficient cold chain solutions, and is the global leader in active temperature control for air transportation of temperature-sensitive pharmaceuticals
- EQT Private Equity and Mubadala will support Envirotainer in its next phase of growth, by accelerating expansion in core markets and APAC in particular, scaling the newly launched CryoSure offering, investing in new technologies and continuing to roll-out third generation Releye platform
EQT is pleased to announce that the EQT X fund ("EQT Private Equity"), and
Envirotainer was founded in 1985 in
Millions of people across the globe depend on the safe delivery of biopharmaceuticals that require temperature control to maintain their integrity and quality. Today, lack of access to medicines is a cause for distress that disproportionately impacts underserved communities, whose situation is likely to be exacerbated by chronic diseases resulting from changing diets and lifestyles, as well as from air and water pollution. Envirotainer expands access to vital pharmaceuticals and vaccines through its patient-safe, reliable and efficient cold chain solutions, which also offer one of the lowest carbon footprint solutions in the industry.
EQT Private Equity and Mubadala will seek to support Envirotainer in its next phase of growth by accelerating expansion in APAC and continuing growth in its other core markets, and will leverage EQT's local-with-locals approach and Mubadala's global network to do so. Building on the sector-related expertise of EQT's network and Mubadala, EQT Private Equity and Mubadala will help scale the newly launched CryoSure offering and continue the successful roll-out of third-generation Releye platform, while investing behind new technology innovations, digitalization and sustainability in its operations.
Camilla Macapili Languille, Head of Life Sciences for Mubadala, said, "Envirotainer plays a mission-critical role in the healthcare ecosystem by ensuring the safe and reliable delivery of drugs from pharma companies to hospitals, clinics, and ultimately, patients. Their extensive international footprint ideally positions Envirotainer to meet the pharma industry's growing need for global temperature-controlled distribution and as the undisputed market leader, they are continuing to pioneer developments in the sector with forward-thinking R&D innovation. We have strong conviction in the company's growth trajectory and will work closely with management and our partners at EQT to ensure its long-term success."
EQT and Mubadala were advised by
The transaction is subject to customary conditions and approvals and is expected to close in Q3 2022. With the acquisition of Envirotainer, EQT X (target fund size of
Contact
EQT Press Office, press@eqtpartners.com, +46 8 506 55 334
The information contained herein does not constitute an offer to sell, nor a solicitation of an offer to buy, any security, and may not be used or relied upon in connection with any offer or solicitation. Any offer or solicitation in respect of EQT X will be made only through a confidential private placement memorandum and related documents which will be furnished to qualified investors on a confidential basis in accordance with applicable laws and regulations. The information contained herein is not for publication or distribution to persons in
About EQT
EQT is a purpose-driven global investment organization with
More info: www.eqtgroup.com
Follow EQT on LinkedIn, Twitter, YouTube and Instagram
About
Mubadala's
More info:www.mubadala.com
About Envirotainer
Envirotainer is the undisputed global market leader in secure cold-chain solutions for intercontinental transport of pharmaceuticals. The company develops, manufactures, and offers leasing of innovative
container solutions and dewars for cryogenic shipping, including validation, support, and service, for pharma products that require a controlled environment. Thanks to a truly global presence with the world's largest active container fleet, the most extensive network, and more than 35 years of industry expertise, Envirotainer is able to meet the customers' need for innovative and reliable solutions - available from any location to any destination. The company operates through an open, global network of airlines, forwarders and couriers and the headquarters is located outside of
For more information, please visit www.envirotainer.com
https://news.cision.com/eqt/r/eqt-private-equity-and-mubadala-to-acquire-envirotainer--the-leading-global-provider-of-mission-crit,c3580034
https://mb.cision.com/Main/87/3580034/1588745.pdf
https://news.cision.com/eqt/i/envirotainer,c3057552
(c) 2022 Cision. All rights reserved., source